Integrative analysis of metabolite GWAS illuminates the molecular basis of pleiotropy and genetic correlation

  1. Courtney J Smith  Is a corresponding author
  2. Nasa Sinnott-Armstrong  Is a corresponding author
  3. Anna Cichońska
  4. Heli Julkunen
  5. Eric B Fauman
  6. Peter Würtz
  7. Jonathan K Pritchard  Is a corresponding author
  1. Stanford University, United States
  2. Fred Hutchinson Cancer Research Center, United States
  3. Nightingale Health Plc, Finland
  4. Pfizer, United States

Abstract

Pleiotropy and genetic correlation are widespread features in GWAS, but they are often difficult to interpret at the molecular level. Here, we perform GWAS of 16 metabolites clustered at the intersection of amino acid catabolism, glycolysis, and ketone body metabolism in a subset of UK Biobank. We utilize the well-documented biochemistry jointly impacting these metabolites to analyze pleiotropic effects in the context of their pathways. Among the 213 lead GWAS hits, we find a strong enrichment for genes encoding pathway-relevant enzymes and transporters. We demonstrate that the effect directions of variants acting on biology between metabolite pairs often contrast with those of upstream or downstream variants as well as the polygenic background. Thus, we find that these outlier variants often reflect biology local to the traits. Finally, we explore the implications for interpreting disease GWAS, underscoring the potential of unifying biochemistry with dense metabolomics data to understand the molecular basis of pleiotropy in complex traits and diseases.

Data availability

The source data and analyzed data have been deposited in Dryad. Code are available at the github link (https://github.com/courtrun/Pleiotropy-of-UKB-Metabolites). The raw individual level data are available through application to UK Biobank.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Courtney J Smith

    Department of Genetics, Stanford University, Stanford, United States
    For correspondence
    courtrun@stanford.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7812-0083
  2. Nasa Sinnott-Armstrong

    Herbold Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, United States
    For correspondence
    nasa@fredhutch.org
    Competing interests
    No competing interests declared.
  3. Anna Cichońska

    Nightingale Health Plc, Helsinki, Finland
    Competing interests
    Anna Cichońska, is a former employee and holds stock options with Nightingale Health Plc..
  4. Heli Julkunen

    Nightingale Health Plc, Helsinki, Finland
    Competing interests
    Heli Julkunen, is an employee and holds stock options with Nightingale Health Plc..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4282-0248
  5. Eric B Fauman

    Internal Medicine Research Unit, Pfizer, Cambridge, United States
    Competing interests
    Eric B Fauman, is affiliated with Pfizer Worldwide Research, has no financial interests to declare, contributed as an individual and the work was not part of a Pfizer collaboration nor was it funded by Pfizer..
  6. Peter Würtz

    Nightingale Health Plc, Helsinki, Finland
    Competing interests
    Peter Würtz, is an employee and shareholder of Nightingale Health Plc..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5832-0221
  7. Jonathan K Pritchard

    Departments of Genetics and Biology, Stanford University, Stanford, United States
    For correspondence
    pritch@stanford.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8828-5236

Funding

Stanford Knight-Hennessy Scholars Program (Graduate Student Fellowship)

  • Courtney J Smith

National Science Foundation (Graduate Student Fellowship)

  • Courtney J Smith

National Institute of Health (5R01HG011432 and 5R01AG066490)

  • Jonathan K Pritchard

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants provided written informed consent and ethical approval was obtained from the North West Multi-Center Research Ethics Committee (11/NW/0382). The current analysis was approved under UK Biobank Project 24983 and 30418.

Copyright

© 2022, Smith et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,934
    views
  • 699
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Courtney J Smith
  2. Nasa Sinnott-Armstrong
  3. Anna Cichońska
  4. Heli Julkunen
  5. Eric B Fauman
  6. Peter Würtz
  7. Jonathan K Pritchard
(2022)
Integrative analysis of metabolite GWAS illuminates the molecular basis of pleiotropy and genetic correlation
eLife 11:e79348.
https://doi.org/10.7554/eLife.79348

Share this article

https://doi.org/10.7554/eLife.79348

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Jessica Gray, Von Vergel L Torres ... Ian R Henderson
    Research Article

    Klebsiella pneumoniae is a global public health concern due to the rising myriad of hypervirulent and multidrug-resistant clones both alarmingly associated with high mortality. The molecular mechanisms underpinning these recalcitrant K. pneumoniae infection, and how virulence is coupled with the emergence of lineages resistant to nearly all present-day clinically important antimicrobials, are unclear. In this study, we performed a genome-wide screen in K. pneumoniae ECL8, a member of the endemic K2-ST375 pathotype most often reported in Asia, to define genes essential for growth in a nutrient-rich laboratory medium (Luria-Bertani [LB] medium), human urine, and serum. Through transposon directed insertion-site sequencing (TraDIS), a total of 427 genes were identified as essential for growth on LB agar, whereas transposon insertions in 11 and 144 genes decreased fitness for growth in either urine or serum, respectively. These studies not only provide further knowledge on the genetics of this pathogen but also provide a strong impetus for discovering new antimicrobial targets to improve current therapeutic options for K. pneumoniae infections.

    1. Developmental Biology
    2. Genetics and Genomics
    Nathan D Harry, Christina Zakas
    Research Article

    New developmental programs can evolve through adaptive changes to gene expression. The annelid Streblospio benedicti has a developmental dimorphism, which provides a unique intraspecific framework for understanding the earliest genetic changes that take place during developmental divergence. Using comparative RNAseq through ontogeny, we find that only a small proportion of genes are differentially expressed at any time, despite major differences in larval development and life history. These genes shift expression profiles across morphs by either turning off any expression in one morph or changing the timing or amount of gene expression. We directly connect the contributions of these mechanisms to differences in developmental processes. We examine F1 offspring – using reciprocal crosses – to determine maternal mRNA inheritance and the regulatory architecture of gene expression. These results highlight the importance of both novel gene expression and heterochronic shifts in developmental evolution, as well as the trans-acting regulatory factors in initiating divergence.